Pieris Pharma (PIRS) Reports Q1 Loss of $0.19/Share

Pieris Pharma (NASDAQ: PIRS) reported Q1 EPS of ($0.19), versus ($0.10) reported last year. Revenue for the quarter came in at $1.34 million, versus $1.25 million reported last year.

For earnings history and earnings-related data on Pieris Pharma (PIRS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• DocGo (DCGO) Misses Q2 EPS by 6c; Offers Guidance
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c